Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis.
about
Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesiaPharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysisUpdate on schizophrenia and bipolar disorder: focus on cariprazineGenetic variation in the human brain dopamine system influences motor learning and its modulation by L-DopaGenetics of adverse reactions to haloperidol in a mouse diallel: a drug-placebo experiment and Bayesian causal analysis.Antipsychotic-induced vacuous chewing movements and extrapyramidal side effects are highly heritable in mice.BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysisDopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression.Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disordersPharmacogenetics of antipsychotics.Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders.Antipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective studyPharmacogenetics and antipsychotics: therapeutic efficacy and side effects predictionThe promise and reality of pharmacogenetics in psychiatryPharmacogenetics of antipsychotic-induced side effectsEthical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in miceLessons from pharmacogenetics and metoclopramide: toward the right dose of the right drug for the right patient.Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice.Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations.Pharmacogenetics in psychiatry: are we ready for widespread clinical use?Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.The role of pharmacogenetics in treating central nervous system disorders.Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations.Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.Pharmacogenetic considerations in the treatment of psychiatric disorders.The intersection of pharmacology, imaging, and genetics in the development of personalized medicine.Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.Pharmacogenetics of response to antipsychotics in patients with schizophrenia.Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.The role of pharmacogenetics in nonmalignant gastrointestinal diseases.Pharmacogenetics: a reality or misplaced optimism?Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis.Cariprazine for the Treatment of Bipolar Disorder.Pharmacogenetics of tardive dyskinesia: an updated review of the literature.Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?Association between genetic variation in the dopamine system and motor recovery after stroke.Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions.Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
P2860
Q24235122-EB5033B7-AE6C-4202-8CC2-07702105A063Q24600775-BCB831F5-2690-4534-8045-0A149F4F86C6Q26741533-E8E0533E-7657-429F-BA30-E05D5936C7B9Q28486256-8A4C56DC-BD9D-4F2E-BFAD-E9F04FAF97D5Q30445406-D85C4F9C-EBD0-44D0-898C-22B12FB2799BQ30501284-98785D70-119E-403B-9F08-C35F10D45F2FQ33566832-38913402-C7A6-41EF-8D18-F1A9F5112A5AQ33623531-8E6F28BC-55DD-431F-9E50-75905B69ED50Q33664787-3B608806-87F6-469B-842C-758EAB8D819EQ33836837-6000345C-A85E-4851-91F9-834C857564D6Q34473834-F2834C00-6876-4F1E-882F-D576A5287994Q34506671-55E766F2-72EA-41F2-BFC6-8633EBA6660FQ34676533-0736F5C2-3E8E-41B5-B9F0-3FC3B43309D1Q35226451-F30B5F14-E125-4578-8DFC-2B4C7858A5CFQ35237129-E9545E31-2329-42C3-AC0F-B120583A2A4AQ35693061-AC406A94-7BCA-4C23-950A-245487ECA8AAQ35974641-A1F32C12-640D-44C3-B309-246E49475899Q36028732-04C8D91F-B5B6-4D74-8F19-1B59FAC33FA7Q36702588-AD35C601-72CB-4356-8DE4-47E728979CAEQ36727004-58FFB353-9167-4F5D-A05D-8CD7D12C3539Q36806137-2F712E22-2559-4736-8169-74116E44C131Q37076472-C5120EF6-32BA-4930-B110-B288254FF2EDQ37264543-F64E1CF6-18E4-4C34-AADB-113EAF55A19EQ37292132-4AA143AF-345C-4E1D-A70B-C5C3A92DB1C1Q37344782-554FB22A-0D8B-40AF-A77D-E03A1BCA8C93Q37678047-DA4CB2F2-CB43-4153-B94E-E82EC9A8C668Q37681573-BA299958-7EEB-437B-82D6-E694758FD30DQ37687997-C657C517-F021-4861-B751-7946CFAF01F8Q37791156-A8F6C7BC-112B-4006-91ED-16034C83EAAFQ37952823-5563A796-E37C-4A18-A03D-4D93A96B6795Q37960512-902FD6B3-0357-4C1D-96D1-679D4679D46EQ37981892-22C7A0E5-5DF8-4EFE-9F04-0AF4FE73A69FQ38003392-40D9CEC4-1D3E-420D-934A-0C6E6C2691F0Q38032249-4C6F15CF-5823-4B60-BCB1-D08BC9CA3368Q38802226-DAC980CE-D8BB-493B-81DA-AC6CD223D36EQ38911685-5256EB13-9927-422E-B527-79045F6E3927Q39238772-3379B868-52EF-4D73-A629-11D12DF313C7Q39334932-FB19601F-6FD6-4E5B-ADF3-38CA19460B9CQ40136199-D14A6DAE-D9A0-4773-88FF-264F9E0A03D4Q42750226-2237AE3E-2CA7-4592-8949-5E426499856C
P2860
Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Antipsychotic-induced tardive ...... he DRD3 gene: a meta analysis.
@ast
Antipsychotic-induced tardive ...... he DRD3 gene: a meta analysis.
@en
type
label
Antipsychotic-induced tardive ...... he DRD3 gene: a meta analysis.
@ast
Antipsychotic-induced tardive ...... he DRD3 gene: a meta analysis.
@en
prefLabel
Antipsychotic-induced tardive ...... he DRD3 gene: a meta analysis.
@ast
Antipsychotic-induced tardive ...... he DRD3 gene: a meta analysis.
@en
P1476
Antipsychotic-induced tardive ...... he DRD3 gene: a meta analysis.
@en
P2093
P Roberto Bakker
Peter N van Harten
P304
P356
10.1016/J.SCHRES.2006.01.010
P407
P50
P577
2006-03-02T00:00:00Z